JBiSE  Vol.4 No.12 , December 2011
Embryoprotein TWIST distribution in breast cancer cells MDA-MB-231 treated with 5-Fluorouracil and malnutrition
ABSTRACT
TWIST is a transcription factor that belongs to the family of helix-loop-helix proteins involved in metastasis with essential role regulating cell movement during early development, as well as in the tumor progression and metastasis of many cancers including breast cancer. It will be interesting to study the relation among cancer chemotherapy, malnutrition and the transcription factors like TWIST in order to explore the risk to metastasis. We used breast cancer line MDA-MB-231. Cell cultures were treated with 5-Fluorouracil (5-Fu), as well as changes in serum and nonessentials amino acid (NEAA), to explore the cell viability and the cellular distribution of TWIST by immunocytochemistry. Our results indicate that cell viability decreased significantly with 5-Fu treatment whereas no changes were observed in malnutrition treatment. On the other hand, TWIST protein significantly increased its distribution in cytoplasm of treated groups with malnutrition as well as in those treated with 5-Fu compared with the control. These results suggest that TWIST translocation was modified by the treatments and further studies are necessary to suggest that TWIST could be a tag protein to avoid metastasis.

Cite this paper
nullEscobar-Cabrera, J. , Rodríguez-Torres, A. , Berumen-Segura, L. and Alcocer, G. (2011) Embryoprotein TWIST distribution in breast cancer cells MDA-MB-231 treated with 5-Fluorouracil and malnutrition. Journal of Biomedical Science and Engineering, 4, 750-754. doi: 10.4236/jbise.2011.412092.
References
[1]   Yang, J., Mani, S., Donaher, J., Ramaswamy, S., Itzykson, R., Come, C., Savagner, P., Gitelman, I., Richardson, A. and Weinberg, R.A. (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell, 117, 927-939. doi:10.1016/j.cell.2004.06.006

[2]   Puisieux, A., Valsesia-Wittmann, S. and Ansieau, S. (2006) A twist for survival and cancer progression. British Journal of Cancer, 94, 13-17. doi:10.1038/sj.bjc.6602876

[3]   Vesuna, F., Diest, P., Chen, J.H. and Raman, V. (2008) Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. Biochemical and Biophysical Research Communications, 367, 235-241. doi:10.1016/j.bbrc.2007.11.151

[4]   Hamamori, Y., Wu, H.Y., Sartorelli, V. and Kedes, L. (1997) The basic domain of myogenic basic helix-loop-helix (bHLH) Proteins Is the Novel Target for Direct Inhibition by Another bHLH protein, twist. Molecular and Cellular Biology, 17, 6563-6573.

[5]   Sosic, D. and Olson, E.N. (2003) A new twist on twist: Modulation of the NF-KappaB pathway. Cell Cycle, 2, 76-78. doi:10.4161/cc.2.2.338

[6]   Cheng, G.Z., Zhang, W.Z., Sun, M., Wang, Q., Coppola, D., Mansour, M., Xu, L.M., Costanzo, C., Cheng, J.Q. and Wang, L.H. (2008) Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function. The Journal of Biological Chemistry, 283, 14665- 14673. doi:10.1074/jbc.M707429200

[7]   Valdés-Mora, F., Gómez del Pulgar, T., Bandrés, E., Cejas, P., Ramírez, A., Pérez-Palacios, R., Gallego-Ortega, D., García-Cabezas, M.A., Casado, E., Larrauri, J., Nistal, M., González-Barón, M., García-Foncillas, J. and Lacal, J.C. (2009) Twist 1 overexpression is associated with nodal invasion and male sex in primary colorectal cancer. Annals of Surgical Oncology, 16, 78-87. doi:10.1245/s10434-008-0166-x

[8]   Maruvada, P. and Srivastava, S. (2004) Biomarkers for cancer diagnosis: Implications for nutritional research. The Journal of Nutrition, 134, 1640S-1645S.

[9]   Cheng, G.Z., Zhang, W. and Wang, L.H. (2008) Regulation of cancer cell survival, migration, and invasion by Twist: AKT2 comes to interplay. Cancer Research, 68, 957-960. doi:10.1158/0008-5472.CAN-07-5067

[10]   Shiota, M., Izumi, H., Onitsuka, T., Miyamoto, N., Kashiwagi, E., Kidani, A., Yokomizo, A., Naito, S. and Kohno, K. (2008) Twist promotes tumor cell growth through YB-1 expression. Cancer Research, 68, 98-105. doi:10.1158/0008-5472.CAN-07-2981

[11]   Mehrotra, J., Vali, M., McVeigh, M., Kominsky, S.L., Fackler, M.J., Lahti-Domenici, J., Polyak, K., Sacchi, N., Garrett-Mayer, E., Argani, P. and Sukumar, S. (2004) Very high frequency of hypermethylated genes in breast cancer metastasis to the bone, brain, and lung. Clinical Cancer Research, 10, 3104-3109. doi:10.1158/1078-0432.CCR-03-0118

[12]   Ciccolini, J., Peillard, L., Aubert, C., Formento, P., Milano, G. and Catalin, J. (2000) Monitoring of the intracellular activation of 5-fluorouracil to deoxyribonucleotides in HT29 human colon cell line: Application to modulation of metabolism and cytotoxicity study. Fundamental and Clinical Pharmacology, 14, 147-154. doi:10.1111/j.1472-8206.2000.tb00403.x

[13]   García-Gasca, T., Salazar-Olivo, L.A., Mendiola-Olaya, E. and Blanco-Labra, A. (2002) The effects of a protease inhibitor fraction from tepary bean (Phaseolus acutifolius) on in vitro cell proliferation and cell adhesion of transformed cells. Toxicology in Vitro, 16, 229-233. doi:10.1016/S0887-2333(02)00006-1

[14]   Ganguly, S., Ashley, L.A., Pendleton, C.M., Grey, R.D., Howard, G.C., Castle, L.D., Peyton, D.K., Fultz, M.E. and DeMoss, D.L. (2008) Characterization of osteoblastic properties of 7F2 and UMR-106 cultures after acclimation to reduced levels of fetal bovine serum. Canadian Journal of Physiology and Pharmacology, 86, 403-415. doi:10.1139/Y08-055

[15]   Lui, K.O., Waldmann, H. and Fairchild, P.J. (2009) Embryonic stem cells: Overcoming the immunological barriers to cell replacement therapy. Current Stem Cell Research and Therapy, 4, 70-80. doi:10.2174/157488809787169093

[16]   Zanghi, J.A., Fussenegger, M. and Bailey, J.E. (1999) Serum protects protein-free competent Chinese hamster ovary cells against apoptosis induced by nutrient deprivation in batch culture. Biotechnology and Bioengineering, 64, 108-119. doi:10.1002/(SICI)1097-0290(19990705)64:1<108::AID-BIT12>3.0.CO;2-B

[17]   De Castro, M., Orive, G., Gascón, A.R., Hernández, R.M. and Pedraz, J.L. (2006) Evaluation of human serum albumin as a substitute of fetal bovine serum for cell culture. International Journal of Pharmaceutics, 310, 8-14. doi:10.1016/j.ijpharm.2005.10.028

[18]   Medina, M.A. (2001) Glutamine and Cancer. The Journal of Nutrition, 131, 2539S-2542S.

[19]   Pan, Y., Bender, P., Akers, R. and Webb, K. (1998) One or more serum factors promote peptide utilization in cultured animal cells. The Journal of Nutrition, 128, 744- 750.

[20]   Kamath, S., Conrad, N., Olson, R., Bess, M., Mid, O. and Ghosh, L. (1988) Amino acid-restricted diets in the treatment of mammary adenocarcinoma in mice. The Journal of Nutrition, 118, 1137-1142.

[21]   Theuer, R.C. (1971) Effect of essential amino acid restriction on the growth of female C57BL mice and their implant BW1023 adenocarcinomas. The Journal of Nutrition, 101, 223-232.

[22]   Worthington, B., Yrotuck, J. and Ahmed, S. (1978) Effects of essential amino acid deficiencies on syngeneic tumor inmmunity and carcinogenesis in mice. The Journal of Nutrition, 108, 1402-1411.

[23]   Yen, C., Mar, M., Craciunescu, C., Edwards, L. and Zeisel, S. (2002) Deficiency in methionine, tryptophan, isoleucine, or choline induces apoptosis in cultured cells. The Journal of Nutrition, 132, 1840-1847.

[24]   Choudry, H.A., Pan, M., Karinch, A.M. and Souba, W.W. (2006) Branched-chain amino acid-enriched nutritional support in surgical and cancer patients. The Journal of Nutrition, 136, 314S-318S.

[25]   Sawada, K., Noda, K., Nakajima, H., Shimbara, N., Furuichi, Y. and Sugimoto, M. (2005) Differential cytotoxicity of anticancer agents in pre- and post-immortal lym-phoblastoid cell lines. Biological and Pharmaceutical Bulletin, 28, 1202-1207. doi:10.1248/bpb.28.1202

[26]   Misaki, T., Iwata, M., Iida, Y., Kasagi, K. and Konishi, J. (2002) Chemo-radionuclide therapy for thyroid cancer: Initial experimental study with cultured cells. Annals of Nuclear Medicine, 16, 403-408. doi:10.1007/BF02990078

[27]   Brunetti, I., Falcone, A., Calabresi, P., Goulette, F. and Darnowski, J. (1990) 5-Fluorouracil enhances azidothymidine cytotoxicity: in vitro, in vivo, and biochemical studies. Cancer Research, 50, 4026-4031.

[28]   Tillman, D.M., Petak, I. and Houghton, J.A. (1999) A fas-dependent component in 5-fluorouracil/leucovorin-induced cytotoxicity in colon carcinoma cells. Clinical Cancer Research, 5, 425-430.

[29]   Hao, N., Whitelaw, M.L., Shearwin, K.E., Dodd, I.B. and Chapman-Smith, A. (2011) Identification of residues in the N-terminal PAS domains important for dimerization of Arnt and AhR. Nucleic Acids Research, 39, 3695- 3709. doi:10.1093/nar/gkq1336

 
 
Top